Milnacipran for the Pain, Sensory Sensitization and Mood Changes in Knee Osteoarthritis.
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2015
At a glance
- Drugs Milnacipran (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 11 May 2013 Results presented at the 32nd Annual Scientific Meeting of the American Pain Society.
- 23 Jan 2012 New trial record